Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DUX4L1 (Double homeobox protein 4 like 1) is a pseudogene located on chromosome 4q35.2, within a D4Z4 repeat array in the subtelomeric region of chromosome 4[1][10][6]. DUX4L1 is also referred to by aliases such as DUX4 and DUX10 and is related to the DUX4 gene, which encodes a DNA-binding transcription factor involved in the pathophysiology of facioscapulohumeral muscular dystrophy (FSHD)[1][10][4]. However, DUX4L1 itself is classified as a pseudogene or non-coding RNA—there is no robust evidence for active transcription from this locus or for production of a functional protein in vivo[1][10]. Some RT-PCR and in vitro experiments indicate possible transcription of paralogs in certain genetic backgrounds, but DUX4L1 itself appears non-functional as a protein-coding gene[1][10]. Because of this, DUX4L1 is not considered a therapeutic target, and there are no known drugs, mechanisms of action, or established biomarker roles directly associated with DUX4L1[1][6][10]. However, mapping and epigenetic changes around the D4Z4/DUX family repeats, including DUX4L1, are used in research to understand FSHD and selected cancer types such as Ewing's sarcoma, rhabdomyosarcoma, and acute lymphocytic leukemia[1]. Note: DUX4 (not DUX4L1) is a transcription factor with established biological roles and therapeutic interest in FSHD and some cancers[4][7]. Be cautious not to conflate DUX4 (the protein-coding target) with DUX4L1 (the pseudogene)[1][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double homeobox protein 4 like 1 (pseudogene) (DUX4L1).